Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drugs candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.
This is not a financial advice!
Upcoming catalysts 08/31/2024
Block buys and Insider buys recently
Rel. Vol. on 03/12/2024 at 7.45
Cup with Handle ist forming
We need to stay in a bullish overal sentiment of the market. If we see a corretion, this play might doesn't work.
Keep an eye on 3.7 level, needs to get broken for a further upmove. You can take partial profits at these levels if u want to lock in gains.
SL under 1.8
TPs approx. 5.3
Most info on the chart.
Trade carefully!
This is not a financial advice!
Upcoming catalysts 08/31/2024
Block buys and Insider buys recently
Rel. Vol. on 03/12/2024 at 7.45
Cup with Handle ist forming
We need to stay in a bullish overal sentiment of the market. If we see a corretion, this play might doesn't work.
Keep an eye on 3.7 level, needs to get broken for a further upmove. You can take partial profits at these levels if u want to lock in gains.
SL under 1.8
TPs approx. 5.3
Most info on the chart.
Trade carefully!
Note
Tuesday March 12, 2024LXRX
Block Trade: LXRX 1.0M @ $2.50 at the bid
LXRX
Block Trade: LXRX 500,000 @ $2.55 at the ask
Join Discord channel:
whop.com/marketplace/contingent-traders/
contingenttrader.com/
whop.com/marketplace/contingent-traders/
contingenttrader.com/
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Join Discord channel:
whop.com/marketplace/contingent-traders/
contingenttrader.com/
whop.com/marketplace/contingent-traders/
contingenttrader.com/
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.